Stacie Calad-Thomson, PhD

Written By Guest User
 

Advisor

 
 
 

Stacie Calad-Thomson, PhD, serves as Advisor. Stacie guides BioSymetrics on its drug discovery strategy, with a focus on human-relevant disease biology, and progressing beyond protein targets. Stacie is a rising star in the industry, having already held positions of increasing responsibility at GSK, where she worked for 10+ years, the ATOM Consortium, and Atomwise, in addition to her work consulting with many of the startups currently using machine learning or genomics data to spearhead drug discovery programs.

She received her Bachelor's in Chemistry from University of California, Berkeley and her PhD in Chemistry from University of California, Irvine.

Guest User
Previous

Matthew Fusco
Next

Dave Kokel, PhD